Zacks Research Analysts Decrease Earnings Estimates for SRPT
Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) – Zacks Research decreased their Q1 2025 earnings per share estimates for Sarepta Therapeutics in a report released on Monday, May 5th. Zacks Research analyst S. Ganoria now forecasts that the biotechnology company will post earnings per share of ($2.70) for the quarter, down from their previous estimate […]
Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) – Zacks Research decreased their Q1 2025 earnings per share estimates for Sarepta Therapeutics in a report released on Monday, May 5th. Zacks Research analyst S. Ganoria now forecasts that the biotechnology company will post earnings per share of ($2.70) for the quarter, down from their previous estimate […]
